Kinase Inhibitors in the Treatment of Thyroid Cancer: Institutional Experience

Although most patients with thyroid cancer have a favorable clinical course, some patients develop a more aggressive type of cancer and exhibit more rapid disease progression with worse prognosis. Those patients usually exhibit mutations of proteins such as tyrosine kinase enzymes that play a sig...

Full description

Bibliographic Details
Main Authors: Matea Pešorda, Sanja Kusačić Kuna, Dražen Huić, Davorin Herceg, Marija Despot, Tatjana Samardžić, Milena Gnjidić, Borislav Belev
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2020-01-01
Series:Acta Clinica Croatica
Subjects:
Online Access:https://hrcak.srce.hr/file/360861